The PAX5 Gene Leukemia Acute Lymphoblastic Susceptibility Test is a genetic examination aimed at identifying mutations in the PAX5 gene, which have been linked to an increased risk of developing acute lymphoblastic leukemia (ALL). The PAX5 gene plays a crucial role in the development and function of B cells, an essential component of the immune system. Mutations in this gene can disrupt normal B cell development, leading to the onset of ALL, a type of cancer that affects the white blood cells and progresses rapidly.
Conducted at DNA Labs UAE, this test is a vital tool for individuals with a family history of leukemia or early symptoms of the disease. By analyzing a sample of the patient's DNA, the test can detect specific germline mutations in the PAX5 gene, helping in the assessment of an individual's susceptibility to ALL. The results can guide healthcare professionals in making informed decisions about monitoring strategies, preventive measures, or early interventions to manage the risk.
The cost of the PAX5 Gene Leukemia Acute Lymphoblastic Susceptibility Test at DNA Labs UAE is 4400 AED. Given the complexity of the analysis and the potential implications for the patient's health management, the test represents a significant investment in personal health and preventive care. Individuals considering this test are advised to consult with a genetic counselor or a healthcare provider to fully understand the potential benefits, limitations, and implications of the test results.
The JAK2 Gene Leukemia Acute Myelogenous Genetic Test is a specialized diagnostic tool used to detect mutations in the JAK2 gene, which are commonly associated with various types of blood cancers, including acute myelogenous leukemia (AML). This test plays a crucial role in the diagnosis and management of AML, helping healthcare professionals to tailor treatment plans based on the genetic makeup of the leukemia. The presence of JAK2 mutations can influence the prognosis and response to certain therapies, making this test an essential part of the diagnostic process.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test offers precise and reliable results. The cost of the JAK2 Gene Leukemia Acute Myelogenous Genetic Test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the JAK2 gene mutations. By opting for this test, patients and healthcare providers can gain valuable insights into the genetic factors of AML, facilitating more effective and personalized treatment strategies.
The MSH6 gene plays a crucial role in DNA mismatch repair, a process essential for maintaining genomic stability. Mutations in the MSH6 gene are associated with Lynch syndrome, also known as Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Type 5, which significantly increases the risk of developing colorectal cancer and other types of cancer. The MSH6 Gene Colorectal Cancer Hereditary Nonpolyposis Type 5 Genetic Test is a specialized diagnostic tool designed to detect mutations in the MSH6 gene. This test is pivotal for individuals with a family history of Lynch syndrome or those who meet certain clinical criteria, as it can confirm the diagnosis and inform appropriate cancer surveillance and management strategies. The test is available at DNA Labs UAE, a leading facility in genetic diagnostics, at a cost of 4400 AED. Identifying MSH6 gene mutations not only aids in the early detection and prevention of colorectal cancer in at-risk individuals but also facilitates informed decisions regarding family planning.
The TGFBR2 gene plays a critical role in the regulation of cellular processes, including cell growth, differentiation, and apoptosis. Mutations in the TGFBR2 gene are associated with an increased risk of developing colorectal cancer, specifically hereditary nonpolyposis colorectal cancer type 6 (HNPCC6), also known as Lynch syndrome type 6. This condition is characterized by an inherited predisposition to colorectal cancer as well as other types of cancer, often occurring at a younger age than typically observed in the general population.
To identify individuals at risk, genetic testing for mutations in the TGFBR2 gene can be conducted. In the UAE, DNA Labs offers a comprehensive genetic test for this purpose. The test involves analyzing the patient's DNA to detect mutations in the TGFBR2 gene that are known to increase the risk of colorectal cancer. The cost of this genetic test is 4400 AED.
Undergoing this genetic test is crucial for individuals with a family history of colorectal cancer or related cancers, as it can provide valuable information for risk assessment and management. A positive result may lead to recommendations for increased surveillance, lifestyle modifications, and possibly preventive interventions to reduce the risk of cancer development. Conversely, a negative result can provide reassurance to the individual and their family members about their genetic risk.
DNA Labs UAE provides this test with the aim of offering personalized risk assessment and contributing to the early detection and prevention of colorectal cancer in the population.
The "MLH3 Gene Colorectal Cancer Hereditary Nonpolyposis Type 7 Genetic Test" is a specialized diagnostic tool designed to identify mutations in the MLH3 gene, which are linked to an increased risk of developing hereditary nonpolyposis colorectal cancer (HNPCC), also known as Lynch syndrome type 7. This condition is characterized by a higher likelihood of developing colorectal cancer, as well as other types of cancer, at a younger age than the general population. The test is crucial for individuals with a family history of colorectal cancer or those who meet specific clinical criteria suggesting the presence of Lynch syndrome.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or cheek swab. The sample is then analyzed to detect any mutations in the MLH3 gene that are known to contribute to the development of this hereditary cancer syndrome. The results from this test can provide valuable information for affected individuals and their families regarding their risk of cancer, enabling them to make informed decisions about their health, including taking preventative measures or undergoing more frequent screenings.
The cost of the MLH3 Gene Colorectal Cancer Hereditary Nonpolyposis Type 7 Genetic Test at DNA Labs UAE is 4400 AED. Given the potential life-saving implications of early detection and intervention, this test represents a critical step for at-risk individuals in managing and mitigating the risks associated with hereditary colorectal cancer.
The EPCAM gene colorectal cancer hereditary nonpolyposis type 8 genetic test is a specialized diagnostic procedure offered at DNA Labs UAE. This test is designed to identify mutations in the EPCAM gene, which are linked to an increased risk of developing colorectal cancer as part of Lynch syndrome, also known as hereditary nonpolyposis colorectal cancer (HNPCC) type 8. Lynch syndrome is the most common hereditary form of colorectal cancer and can also increase the risk of other types of cancer.
The EPCAM gene plays a crucial role in cell signaling and adhesion, and mutations in this gene can lead to abnormal cell growth and cancer. Identifying individuals with these mutations enables healthcare providers to implement targeted surveillance strategies, early interventions, and personalized treatment plans to manage the increased cancer risk.
The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of EPCAM gene mutations. DNA Labs UAE, known for its state-of-the-art facilities and expertise in genetic testing, offers this test at a cost of 4400 AED. The test is recommended for individuals with a family history of Lynch syndrome or colorectal cancer, as well as those who have personal health histories that suggest an increased risk of these conditions. By providing critical genetic information, the EPCAM gene test is a valuable tool in the prevention and early detection of colorectal cancer and related cancers in at-risk populations.
The CCND1 gene plays a significant role in cell cycle regulation, making it a critical factor in understanding the genetic susceptibility to colorectal cancer. The CCND1 Gene Colorectal Cancer Hereditary Susceptibility Genetic Test is a specialized diagnostic tool aimed at identifying mutations or alterations in the CCND1 gene that may increase an individual's risk of developing colorectal cancer. This test is particularly relevant for individuals with a family history of colorectal cancer, as it can provide valuable insights into their genetic predisposition to the disease.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test employs advanced genomic technologies to analyze the CCND1 gene for specific mutations associated with an increased risk of colorectal cancer. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then meticulously examined for any genetic variations in the CCND1 gene.
The cost of the CCND1 Gene Colorectal Cancer Hereditary Susceptibility Genetic Test is 4400 AED. While the price may seem steep, the test offers invaluable information that can empower individuals and their healthcare providers to take proactive steps in managing their cancer risk. This could include more frequent screenings, lifestyle modifications, or even preventative treatments, all aimed at reducing the likelihood of developing colorectal cancer.
Overall, the CCND1 Gene Colorectal Cancer Hereditary Susceptibility Genetic Test is a vital resource for individuals at risk of hereditary colorectal cancer, offering them the chance to take control of their health through informed decision-making.
The PTEN Gene Cowden Syndrome Type 1 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the PTEN gene, which are associated with Cowden Syndrome Type 1. This condition is a rare, autosomal dominant disorder characterized by multiple noncancerous, tumor-like growths called hamartomas and an increased risk of developing certain types of cancer, including breast, thyroid, and endometrial cancer. Early detection through genetic testing can be crucial for affected individuals and their families, as it allows for the implementation of targeted surveillance and preventive measures to manage the associated risks. The test is priced at 4400 AED and provides a comprehensive analysis of the PTEN gene to help in the diagnosis and management of Cowden Syndrome Type 1, thereby offering a valuable resource for individuals with a family history or clinical symptoms suggestive of this genetic condition.
The SDHD Gene Cowden Syndrome Type 3 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the SDHD gene, which are linked to Cowden Syndrome Type 3, a rare genetic disorder characterized by the development of multiple noncancerous, tumor-like growths called hamartomas and an increased risk of certain types of cancer. This test is crucial for individuals with a family history of Cowden Syndrome or those exhibiting symptoms, as early detection can significantly influence management and surveillance strategies for associated malignancies.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, this test offers a comprehensive analysis of the SDHD gene to pinpoint specific mutations. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify these genetic variations. By opting for this test, patients and their healthcare providers can make informed decisions about their health, potentially leading to early intervention and improved outcomes for those affected by Cowden Syndrome Type 3.
The PIK3CA Gene Cowden Syndrome Type 5 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the PIK3CA gene, which are linked to Cowden Syndrome Type 5, a rare genetic disorder. This condition is characterized by the development of multiple noncancerous, tumor-like growths called hamartomas and an increased risk of certain types of cancer, including breast, thyroid, and endometrial cancer. The test is crucial for individuals with a family history of Cowden Syndrome or related symptoms, as it helps in confirming the diagnosis, understanding the risk of associated cancers, and making informed decisions regarding surveillance and management strategies.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test ensures accuracy and confidentiality. The cost of the PIK3CA Gene Cowden Syndrome Type 5 Genetic Test is set at 4400 AED, reflecting the sophisticated technology and expertise involved in conducting the analysis. By opting for this test at DNA Labs UAE, patients and healthcare providers can access critical genetic information that plays a vital role in personalized medical care and the prevention of cancer in susceptible individuals.
